HIV patients have an increased risk of developing skin and mucosal cancers, even though HIV is no longer detectable in their blood due to antiretroviral therapy. A new study by MedUni Vienna's Department of Dermatology, the ...
Nov 23, 2021
0
13
A new technique using electron tomography and subtomogram averaging at Diamond's electron Bio-Imaging Centre (eBIC), has solved the structure of the HIV capsid alone and in complex with host factors. This work also led to ...
Nov 19, 2021
0
132
During infection, HIV places copies of its genome into the DNA of cells, creating what is known as a viral reservoir. In this state, the virus effectively hides from anti-HIV drugs and the body's immune response. In most ...
Nov 15, 2021
0
715
Northwestern Medicine investigators have discovered that a microtubule regulatory protein inhibits early HIV type 1 (HIV-1) infection, according to findings published in Proceedings of the National Academy of Sciences.
Nov 2, 2021
0
36
Research led by scientists at the National Institutes of Health has identified two distinct ways that people with HIV can control the virus for an extended period after stopping antiretroviral therapy (ART) under medical ...
Oct 28, 2021
0
74
For more than 40 years a goal that too often has proved elusive is a pharmaceutical defeat of the human immunodeficiency virus—HIV. And the thrust in recent years has emphasized bringing newer, stealthier weapons to the ...
A new combination treatment for HIV can strengthen a patient's immune response against the virus even after they stop taking traditional medications, according to a study published in the journal Science Immunology we co-led ...
Sep 30, 2021
0
1
Researchers at City of Hope, a world-renowned research and treatment organization for cancer and diabetes, and Menzies Health Institute Queensland at Griffith University have developed a novel anti-HIV protein that suppressed ...
Sep 20, 2021
0
56
HIV is a master of evading the immune system, using a variety of methods to prevent the body from being able to find and kill it. The vast majority of people living with HIV require daily medication to suppress the virus ...
Sep 9, 2021
0
37
Johnson & Johnson's highly anticipated HIV vaccine failed to demonstrate adequate protection in a clinical trial involving more than 2,600 young women in sub-Saharan Africa, the company and US health authorities said Tuesday.
Aug 31, 2021
0
127
